Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 241,017,041 papers from all fields of science
Search
Sign In
Create Free Account
flibanserin
Known as:
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (2)
Addyi
BIMT-17
Broader (1)
Benzimidazoles
flibanserin 100 MG Oral Tablet [Addyi]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Does Flibanserin Have a Future
E. Cooper
,
J. McBride
,
Do
,
S. Levine
2016
Corpus ID: 151272176
Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the…
Expand
2015
2015
FDA approves female sexual dysfunction drug
Asher Mullard
Nature reviews. Drug discovery
2015
Corpus ID: 36380932
2015
2015
Preparation method of flibanserin
Xue-Nong Xu
2015
Corpus ID: 139976444
The invention discloses a preparation method of flibanserin. The preparation method uses trifluoromethylbenzene, triamine (2…
Expand
2015
2015
Flibanserin: More Than Just a “Pink Viagra”
A. Clayton
2015
Corpus ID: 217845767
Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment…
Expand
2010
2010
FDA Lacks Desire for Flibanserin—But Does Hypoactive Sexual Desire Disorder Even Exist?
R. Pies
2010
Corpus ID: 147731446
Consider the predicament of Mrs M—a 38-year old premenopausal mother of two. Mrs M tells her primary care physician, “I just don…
Expand
2010
2010
[The abandonment of the development of flibanserin].
J. Nau
Revue medicale suisse
2010
Corpus ID: 7613810
2008
2008
Sexual dysfunction prevalence rates: marketing or real?
I. Nygaard
Obstetrics and Gynecology
2008
Corpus ID: 205384042
I have long had a problem 1 with the tendency of the health care system, aided and abetted by the pharmaceutical industry, to…
Expand
2007
2007
Flibanserin formulations and manufacturing method thereof
ヴォルフラム アイゼンライッヒ
,
フロリアン ゾンマー
,
トーマス フリートル
,
ナンタラット ペアルンチョブ
,
カール ゲルハルト ワグナー
2007
Corpus ID: 139283510
The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin and…
Expand
2002
2002
Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
봄바르다카를로
,
두비니엔리카
,
에자야안토인
2002
Corpus ID: 132031557
The present invention relates to a replicon polymorph A, during its manufacture a medicament, as well as the technical process…
Expand
1998
1998
FLIBANSERIN : ANTIDEPRESSANT 5-HT1A RECEPTOR AGONIST 5-HT2 RECEPTOR ANTAGONIST
F. Borsini
,
A. Brambilla
,
+5 authors
M. Turconi
1998
Corpus ID: 79172441